Morning Overview on MSN
New research links cancer therapy and synthetic biology in a major leap
Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...
A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Cancer cell biology unravels the molecular and cellular underpinnings of tumour formation, progression and metastasis. At its core, cancer arises as a result of dysregulated cell cycle control, ...
The Brighterside of News on MSN
New study provides a key breakthrough in cancer therapy and synthetic biology
Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.
A new paper published in Nature on June 4 shines light on how an enigmatic part of male aging—the loss of Y chromosomes—is connected with a higher risk of dying from cancer. In an analysis of 4,127 ...
Spatial biology first entered the omics scene about a decade ago. Since then, the technology has generated significant buzz both inside and outside of the lab—beyond its contributions to science. The ...
Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...
Exploring biology in its native environment is perhaps the ideal scenario for generating better hypotheses about the cellular interactions that influence—and drive—healthy and diseased states, ...
T his past year, we explored a lot of new cell biology research—from cancer to plants to microbes, and more! It’s hard to ...
Other diabetes drugs are also being studied. SGLT2 inhibitors and GLP-1 receptor agonists may help reduce inflammation, slow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results